First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
Recruiting · NCT07700160 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-01 | NCT07700160 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VelaVigo Bio Inc | 5 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Beijing GoBroad Hospital | Beijing | China | 14 |
| City of Hope Medical Center | Duarte | United States | 313 |
| GenesisCare North Shore | St Leonards | Australia | 13 |
| Laura and Issac Perlmutter Cancer Center | New York | United States | 1 |
| Next Oncology - Oncology | San Antonio | United States | 1 |
| NEXT Oncology Virginia | Fairfax | United States | 40 |
| One Clinical Research | Perth | Australia | 1 |
| START Midwest, LLC | Grand Rapids | United States | 8 |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 3 |
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |
| Zhongshan Hospital | Shanghai | China | 20 |